ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P4-663: INITIATION OF THE PHASE 2/3 GAIN TRIAL OF COR388, A NOVEL BACTERIAL VIRULENCE FACTOR INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE (AD) BASED ON PHASE I A/B SAFETY, PK, BIOMARKER AND EFFICACY DATA
Alzheimer s & Dementia
◽
10.1016/j.jalz.2019.09.029
◽
2019
◽
Vol 15
◽
pp. P1585-P1585
Author(s):
Mike Detke
◽
Casey Lynch
◽
Leslie Holsinger
◽
Shirin Kapur
◽
Dave Hennings
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase I
◽
Virulence Factor
◽
Bacterial Virulence
◽
Phase 2
◽
Efficacy Data
◽
Factor Inhibitor
◽
Bacterial Virulence Factor
Download Full-text
Related Documents
Cited By
References
An update and baseline data from the phase 2/3 GAIN trial of COR388 (atuzaginstat), a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s disease
Alzheimer s & Dementia
◽
10.1002/alz.050624
◽
2021
◽
Vol 17
(S9)
◽
Author(s):
Mike Detke
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Virulence Factor
◽
Bacterial Virulence
◽
Baseline Data
◽
Phase 2
◽
Factor Inhibitor
◽
Bacterial Virulence Factor
Download Full-text
Faculty Opinions recommendation of A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.5045975.4981082
◽
2010
◽
Author(s):
David Brooks
◽
Nicola Pavese
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Deep Brain Stimulation
◽
Phase I
◽
Brain Stimulation
◽
Phase I Trial
◽
Memory Circuits
◽
Deep Brain
◽
Stimulation Of
Download Full-text
Faculty Opinions recommendation of Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.732699317.793576065
◽
2020
◽
Author(s):
Filippo Drago
◽
Filippo Caraci
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Blind Study
◽
Double Blind Study
◽
Phase 2
◽
Double Blind
Download Full-text
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
Nature Aging
◽
10.1038/s43587-021-00070-2
◽
2021
◽
Vol 1
(6)
◽
pp. 521-534
Author(s):
Petr Novak
◽
Branislav Kovacech
◽
Stanislav Katina
◽
Reinhold Schmidt
◽
Philip Scheltens
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Active Immunotherapy
◽
Phase 2
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
Purification of bacterial virulence factor pertactin using high affinity ligands
Biochemical Engineering Journal
◽
10.1016/j.bej.2020.107760
◽
2020
◽
Vol 164
◽
pp. 107760
Author(s):
Umatheny Umatheva
◽
Braden Sweeting
◽
Léo Sauvaget
◽
Nerissa Dela Rosa
◽
John Riley
◽
...
Keyword(s):
Virulence Factor
◽
Bacterial Virulence
◽
Affinity Ligands
◽
High Affinity
◽
Bacterial Virulence Factor
Download Full-text
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
Alzheimer s Research & Therapy
◽
10.1186/s13195-018-0340-8
◽
2018
◽
Vol 10
(1)
◽
Cited By ~ 15
Author(s):
Ana-María Lacosta
◽
María Pascual-Lucas
◽
Pedro Pesini
◽
Diego Casabona
◽
Virginia Pérez-Grijalba
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase I
◽
Phase I Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Secretion of a bacterial virulence factor is driven by the folding of a C-terminal segment
Proceedings of the National Academy of Sciences
◽
10.1073/pnas.1009491107
◽
2010
◽
Vol 107
(41)
◽
pp. 17739-17744
◽
Cited By ~ 74
Author(s):
Janine H. Peterson
◽
Pu Tian
◽
Raffaele Ieva
◽
Nathalie Dautin
◽
Harris D. Bernstein
Keyword(s):
Virulence Factor
◽
Terminal Segment
◽
Bacterial Virulence
◽
Bacterial Virulence Factor
Download Full-text
O4-11-04: LINKING DIABETES AND ALZHEIMER'S DISEASE THROUGH RAGE: A RETROSPECTIVE ANALYSIS OF AZELIRAGON PHASE 2 AND PHASE 3 STUDIES
Alzheimer s & Dementia
◽
10.1016/j.jalz.2019.06.4803
◽
2019
◽
Vol 15
◽
pp. P1263-P1263
◽
Cited By ~ 2
Author(s):
Carmen Valcarce
◽
Imogene Dunn
◽
Aaron H. Burstein
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Retrospective Analysis
◽
Phase 2
◽
Phase 3
Download Full-text
Longitudinal flortaucipir accumulation is spatially distinct across baseline tau burden stages: Summary from three phase 2/3 interventional trials in Alzheimer’s disease
Alzheimer s & Dementia
◽
10.1002/alz.041815
◽
2020
◽
Vol 16
(S4)
◽
Author(s):
Sergey Shcherbinin
◽
Ixavier A. Higgins
◽
Ming Lu
◽
Michael J. Pontecorvo
◽
Albert C. Lo
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase 2
◽
Three Phase
Download Full-text
P1-392: DRUG DEVELOPMENT FOR AGITATION AND AGGRESSION IN ALZHEIMER'S DISEASE (AD): STUDY DESIGN AND OUTCOME MEASURES IN PHASE 2 STUDY OF SCYLLO-INOSITOL (ELND005 STUDY AG201)
Alzheimer s & Dementia
◽
10.1016/j.jalz.2014.05.634
◽
2014
◽
Vol 10
◽
pp. P458-P458
◽
Cited By ~ 1
Author(s):
Susan R. Abushakra
◽
Patrick Kesslak
◽
Matthias Kurth
◽
Frank Fan
◽
Menghis Bairu
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Drug Development
◽
Outcome Measures
◽
Study Design
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close